BHARATSE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bharat Seats Limited's Board meeting on 6th May 2026 approved the Annual Financial Statements and Audited Financial Results for FY ended 31st March 2026, with S.R. Batliboi & Co. LLP issuing an Unmodified Opinion. The auditors flagged an Emphasis of Matter regarding an Income Tax Department search under Section 132 conducted at the company's manufacturing premises and residences of key personnel in an earlier year, though the opinion remains unmodified. The Board recommended a dividend of Rs. 1.50 per equity share (75% on face value of Rs. 2), payable to shareholders on record as of 17th July 2026. Capital expenditure of approximately Rs. 86.61 crores was approved for new Maruti Suzuki programmes at the Kharkhoda and Gujarat Navyani plants. Mr. Rishabh Relan (son of Chairman & MD Mr. Rohit Relan) has been recommended for re-appointment as Whole-time Director for another three-year term from 4th February 2027. The 39th AGM is scheduled for 24th July 2026.
Positive signals include dividend declaration and substantial capex approval for Maruti Suzuki programmes indicating strong OEM partnership. The Income Tax search matter noted by auditors presents a regulatory risk to monitor closely. The re-appointment of Mr. Rishabh Relan maintains leadership continuity.